Fortis Healthcare Limited has completed the mandatory newspaper publication of its Q3 FY26 unaudited financial results under SEBI regulations, following the company's strong financial performance for the quarter ended December 31, 2025. The healthcare giant reported consolidated revenues of INR 2,265 Cr, marking a significant 17.5% increase compared to Q3 FY25. Subsequently, the company held its earnings conference call on February 16, 2026, providing detailed insights into operational performance and future expansion plans.

Regulatory Compliance and Publication Details

Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published its financial results on February 14, 2026, in English daily "Financial Express" (all editions) and Punjabi daily "Rozana Spokesman" (Mohali edition). The publication ensures transparency and accessibility of financial information to all stakeholders. Additionally, the company released the transcript of its investors/analysts meet held on February 16, 2026, under Regulation 30.

Strong Financial Performance Highlights

The consolidated financial results showcase robust operational efficiency across both hospital and diagnostics businesses, with significant margin expansion and revenue growth. During the earnings call, MD and CEO Dr. Ashutosh Raghuvanshi highlighted the sustained growth momentum despite seasonal impacts from festivals in key geographies.

For the nine-month period ended December 31, 2025, consolidated revenues reached INR 6,763 Cr, demonstrating consistent growth momentum with a 17.1% increase. The company's net debt stands at INR 2,547 Cr with a net debt to EBITDA ratio of 1.24x as of December 31, 2025.

Hospital Business Drives Growth

The hospital business segment emerged as the primary growth driver, with revenues increasing substantially and margins improving across key specialties. Management noted that 13 facilities reported operating EBITDA above 20% during the nine-month period, contributing 77% of hospital revenues.

Strategic Acquisitions and Expansion Plans

During the earnings call, management announced the acquisition of 125-bedded People Tree Hospital in Yeshwanthpur, Bengaluru for INR 430 Cr in January 2026. The acquisition includes underlying land and an adjacent land parcel enabling future expansion to over 300 beds. The company also launched Adayu, a 36-bedded specialized mental health care facility in Gurugram in November 2025.

Diagnostics Business Performance

Agilus Diagnostics reported gross revenues of INR 371 Cr, reflecting 8.3% year-on-year growth. Operating EBITDA margin improved significantly to 23.1% from 14.4% in Q3 FY25. The business conducted 9.9 million tests during the quarter with a balanced B2C-B2B mix of 52-48.

Management Outlook and Future Strategy

CFO Vivek Goyal indicated expectations of continued growth trajectory with 4-5% ARPOB increases going forward. The company expects potential equity infusion from parent IHH Healthcare post the cooling period ending in May 2026. Management expressed confidence in maintaining growth momentum through brownfield expansions, strategic acquisitions, and operational improvements across existing facilities.

Fortis Healthcare Limited has formally notified stock exchanges about comprehensive arrangements for its quarterly financial performance review. The healthcare major will present its third-quarter results to investors and stakeholders through multiple engagement channels following regulatory compliance procedures.

Board Meeting Details

The company has scheduled a Board of Directors meeting for Friday, February 13, 2026, with a specific agenda to consider and approve crucial financial documents. The meeting will focus on reviewing comprehensive financial performance across different business segments.

Conference Call Schedule

Following the board meeting, Fortis Healthcare Limited has arranged a conference call to discuss the financial results with investors and analysts. The virtual meeting will provide detailed insights into the company's quarterly and nine-month performance.

Dial-in Information

The company has provided comprehensive dial-in details for both domestic and international participants to ensure broad accessibility for the conference call.

Trading Window Restrictions

In accordance with regulatory compliance requirements, Fortis Healthcare Limited has implemented mandatory trading restrictions for company securities. The trading window closure ensures fair market practices during the financial results announcement period.

Regulatory Compliance

The board meeting and conference call notifications have been issued in strict compliance with Securities and Exchange Board of India regulations. The company has fulfilled its disclosure obligations under multiple regulatory frameworks to ensure transparency in corporate governance. The notifications were filed under Regulation 29, 30, and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.